| Financial Year |
March 31 2023 |
| Monetary Funds |
756,450,907.36 |
| Held-for-trading Financial Assets |
1,129,065,734.84 |
| Notes Receivable |
377,878,497.24 |
| Accounts Receivable |
762,612,307.71 |
| Advances to Suppliers |
6,616,045.90 |
| Other Receivables |
7,687,967.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
284,336,004.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,244,553.84 |
| Total Current Assets |
3,331,892,018.57 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
30,301,488.86 |
| Fixed Assetes |
914,260,661.97 |
| Under-construction Projects |
325,088,841.31 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
136,628,478.89 |
| R&D expenses |
-- |
| Goodwill |
18,334,711.89 |
| Long-Term Deferred and Prepaid Expenses |
34,760,462.42 |
| Deferred Income Tax Assets |
33,509,649.78 |
| Other Non-Current Assets |
3,276,726.65 |
| Sub-Total of Non-Current Assets |
1,612,721,021.77 |
| Total Assets |
4,944,613,040.34 |
| Short-Term Loans |
100,088,611.11 |
| Trading Financial liabilities |
-- |
| Notes Payable |
664,139,401.55 |
| Accounts Payable |
580,496,294.34 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
60,227,217.63 |
| Taxes Payable |
14,367,544.50 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
60,526,346.27 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
3,328,252.70 |
| Sub-Total of Current Liabilities |
1,485,385,370.66 |
| Long-term Loans |
-- |
| Bonds Payable |
380,729,872.89 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
17,482,425.46 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
473,739,526.96 |
| Total Liabilities |
1,959,124,897.62 |
| Paid-In Capital(Or Share Stock) |
1,342,288,824.00 |
| Capital Surplus |
329,848,538.89 |
| Surplus Reserve |
203,345,178.31 |
| LESS:Treasury Stock |
113,996,905.81 |
| Undistributed Profits |
1,151,181,945.37 |
| Minority Stockholder's Interest |
22,581,975.60 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,962,906,167.12 |
| Owner's Equity（Stockholder's Equity） |
2,985,488,142.72 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,944,613,040.34 |
